Carrie et al.,
Here is their website. It took a bit of hunting to find it when I was
looking for it a few weeks ago. At that time, I got through on the phone
with no problem and they faxed me a list of their products along with the
prices. 

http://www.immunovisiontech.com/

Regards,
Brett

Brett M. Connolly, Ph.D.
Merck Research Laboratories
Dept. of Neuroscience
WP26A-3000
PO Box 4
West Point, PA 19486
PH 215-652-2501
fax. 215-652-2075
e-mail. brett_connolly@merck.com


-----Original Message-----
From: Carrie Kyle-Byrne [mailto:ckbyrne@exelixis.com]
Sent: Thursday, January 30, 2003 2:33 PM
To: 'HistoNet@Pathology.swmed.edu'
Subject: ImmunoVision Technologies


Hi all,
does anyone have contact information for this company?  i tried getting a
phone number from information but when i call the number they gave me no one
answers......not even an answering machine.  i've yet to find a web site for
them and haven't been able to find any product advertising (other than a
handfull of articles written in the last year) for PowerVision+.  i'm
rapidly becoming very skeptical about this outfit.
thanks,
clkb

Carrie Kyle-Byrne, BHS, HT(ASCP)
Assoc. Research Scientist II
Antibody Core Lab
Signal Transduction Research

Exelixis, Inc.
170 Harbor Way
P.O. Box 511
South San Francisco
CA 94083-0511 USA

Phone: (1 650) 837-8023
Fax: (1 650) 837-7240
Email: ckbyrne@exelixis.com

________________________________________________________________
This email message is for the sole use of the intended recipient(s) and may
contain
confidential and privileged information.  Any unauthorized review, use,
disclosure
or distribution is prohibited.  If you are not the intended recipient,
please contact
the sender by reply email and destroy all copies of the original message.





------------------------------------------------------------------------------
Notice:  This e-mail message, together with any attachments, contains information of Merck & Co., Inc. (Whitehouse Station, New Jersey, USA) that may be confidential, proprietary copyrighted and/or legally privileged, and is intended solely for the use of the individual or entity named in this message.  If you are not the intended recipient, and have received this message in error, please immediately return this by e-mail and then delete it.

==============================================================================